Christopher Jewell

No open positions remaining

Net worth: 1 M $ as of 30/06/2026

45 year

Consumer Services

Commercial Services

Profile

Christopher Jewell worked as a Professor at the University of Maryland from 2020 to 2024.
Dr. Jewell served as Chief Scientific Officer at Cartesian Therapeutics, Inc. (United States) in 2023 and continued in the same role at Cartesian Therapeutics, Inc. from 2023 to 2025.
Dr. Jewell earned a doctorate from the University of Wisconsin.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.36%	14/04/2026	104,877 ( 0.36% )	1 M $	30/06/2026

Former positions of Christopher Jewell

Companies	Position	End
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/04/2024
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Chief Tech/Sci/R&D Officer	13/11/2023

See the detail of Christopher Jewell's experience

Training of Christopher Jewell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Jewell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Commercial Services